Mometasone Eg (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Eg, is a corticosteroid presented as a nasal spray formulation for nasal use. It treats allergic rhinitis and nasal polyps in adults and children. GNH USA supplies Mometasone Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a nasal corticosteroid that reduces inflammation in the upper airway.

Allergic rhinitis: alleviates nasal congestion, itching, and sneezing caused by allergic inflammation. Nasal polyps: decreases polyp size and improves nasal airflow. Seasonal allergic rhinitis: provides symptom relief during pollen seasons.

Mometasone furoate may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Throat irritation or dryness - Altered taste or bitter taste - Cough

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Cataract formation or glaucoma - Severe nasal septum perforation - Opportunistic fungal infection of the nasal passages - Systemic immunosuppression leading to increased infection risk - Hypersensitivity reactions such as angioedema

Before using Mometasone Eg, consider the following safety measures.

Use only as prescribed: follow the prescriber's instructions for frequency and duration. Avoid use after recent nasal surgery or trauma: may impair healing. Monitor for signs of infection: discontinue if persistent fungal or bacterial infection develops. Exercise caution in children: lower systemic exposure but monitor growth with long‑term therapy. Limit duration of continuous use: prolonged use can increase risk of systemic effects. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone Eg can interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppressive effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase local exposure. - Antifungal agents that inhibit glucocorticoid metabolism.

Moderate Interactions (Monitor Closely): - Nasal decongestants: may increase local irritation. - Antihistamines: additive sedative effect is unlikely but monitor symptom control. - Immunosuppressants: watch for enhanced suppression of immune response. - Live vaccines: consider timing to avoid reduced vaccine efficacy.